LENZ Therapeutics, Inc. (LENZ) Financials

LENZ Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 236.6 million 17.3 million
March 31, 2026 272.5 million 26.0 million
Dec. 31, 2025 305.9 million 21.5 million
Sept. 30, 2025 210.7 million 16.8 million

LENZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -38.7 million 4.5 million
March 31, 2026 -33.6 million 4.3 million
Dec. 31, 2025 -33.1 million 3.7 million
Sept. 30, 2025 -9.0 million 3.5 million

LENZ Net Income

No data available :(

LENZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 220.0 million - 122000
March 31, 2026 258.4 million - 673000
Dec. 31, 2025 292.3 million - 815000
Sept. 30, 2025 202.2 million - 954000

LENZ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 31.4 million
March 31, 2026 31.4 million
Dec. 31, 2025 31.1 million
Sept. 30, 2025 28.5 million

LENZ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 16000 - 39.4 million -
March 31, 2026 18000 - 44.8 million -
Dec. 31, 2025 38000 - 39.5 million -
Sept. 30, 2025 439000 3.8 million 27.5 million -

LENZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 5.5 million 280000
March 31, 2026 1.9 million 1.2 million
Dec. 31, 2025 1.6 million 525000
Sept. 30, 2025 12.5 million 125000

LENZ Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LENZ

Price: $3.27

52 week price:
3.27
49.85

Earnings Per Share: -4.17 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 112.2 million

Links: